fbpx
June 8, 2020

MusclMasster LLC Issues Voluntary Nationwide Recall of Al-Er-G Capsules Because it Contains the Banned Substance Ephedra

Summary Company Announcement Date: May 23, 2017 FDA Publish Date: February 08, 2018 Product Type: DrugsGeneric DrugsFood & Beverage Safety Reason for Announcement: Recall Reason Description […]
June 8, 2020

SCA Pharmaceuticals LLC. Issues Voluntary Nationwide Recall of Furosemide 100 mg in 0.9% Sodium Chloride Due to Presence of Precipitate

Summary Company Announcement Date: September 05, 2018 FDA Publish Date: March 19, 2020 Product Type: DrugsGeneric Drugs Reason for Announcement: Recall Reason Description Due to Presence […]
June 7, 2020

PharMEDium Services, LLC Issues Voluntary Nationwide Recall of 0.5 mg/mL HYDROmorphone HCl in 0.9% Sodium Chloride 1 mL in 3 mL BD Syringe Due to Presence of Sulfite

Summary Company Announcement Date: June 28, 2019 FDA Publish Date: June 28, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description The electronic customer ordering […]
June 6, 2020

Standard Homeopathic Company Issues Nationwide Recall of Hyland’s Baby Teething Tablets and Hyland’s Baby Nighttime Teething Tablets Due to Mislabeling

Summary Company Announcement Date: April 13, 2017 FDA Publish Date: February 08, 2018 Product Type: DrugsGeneric Drugs Reason for Announcement: Recall Reason Description Mislabeling Company Name: […]
June 6, 2020

Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System Due to the Potential Presence of Particulate Matter

Summary Company Announcement Date: June 04, 2018 FDA Publish Date: June 04, 2018 Product Type: DrugsGeneric Drugs Reason for Announcement: Recall Reason Description Potential of Foreign […]
June 6, 2020

Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a Result of a Sterility Test Failure

Summary Company Announcement Date: May 28, 2019 FDA Publish Date: May 28, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Sterility Failure Company Name: […]
June 5, 2020

Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply

GSMS FG NDCs GSMS FGNDC Description GSMS FG Product Lots GSMS FG Expiration Dates 60429-318-90 Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle GS014045 06/2019 […]
June 5, 2020

Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.

Summary Company Announcement Date: June 10, 2019 FDA Publish Date: June 11, 2019 Product Type: DrugsGeneric Drugs Reason for Announcement: Recall Reason Description Detection of an […]
June 5, 2020

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets

Summary Company Announcement Date: November 16, 2017 FDA Publish Date: December 29, 2017 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Possible Sub […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0